کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4250933 | 1283940 | 2015 | 10 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: PET/CT, MR, and PET/MR in Lymphoma and Melanoma PET/CT, MR, and PET/MR in Lymphoma and Melanoma](/preview/png/4250933.png)
With the introduction of hybrid imaging technologies such as PET/CT and recently PET/MRI, staging and therapy-response monitoring have evolved. PET/CT has been shown to be of value for routine staging of FDG-avid lymphomas before as well as at the end of treatment. For interim staging, trials are ongoing to evaluate the use of PET/CT. In melanoma, PET/CT can be recommended for stages III and IV diseases for initial staging and before surgery. Studies investigating the use of PET/CT for early therapy response are promising. The role of PET/MR in lymphoma and melanoma imaging has to be defined because no larger studies exist so far. There may be an application of PET/MR in research especially for tumor characterization and therapy response. Furthermore, the potential role of non-FDG tracers is elucidated regarding the assessment of treatment response in targeted drug regimens.
Journal: Seminars in Nuclear Medicine - Volume 45, Issue 4, July 2015, Pages 322–331